Human Recombinant BFGF, ACF, 100 µg

Overview:
Basic fibroblast growth factor (bFGF) is a prototypic member of the fibroblast growth factor family. Cytokines in the FGF family possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including cell proliferation, differentiation, survival, and apoptosis. bFGF has the ?-trefoil structure, binds to the four FGF receptor (FGFR) family members, and activates JAK/STAT, PI3K, ERK1/2, and other receptor tyrosine kinase (RTK) signaling pathways. It supports the maintenance of undifferentiated human pluripotent stem cells, stimulates human pluripotent stem cells to form neural rosettes, and improves proliferation of human mesenchymal stem cells and enhances chondrogenic differentiation. This version of bFGF is the full-length bFGF protein encoded by the human FGF2 gene consisting of 154 amino acid residues. This product is animal component-free.

Specifications:

• Catalog Number: 78134.1
• Quantity: 100 µg
• Purity: ? 95%
• Formulation Category: Animal Component-Free
• Cell Type: Brain Tumor Stem Cells; Endoderm, PSC-Derived; Hematopoietic Stem and Progenitor Cells; Mesenchymal Stem and Progenitor Cells; Mesoderm, PSC-Derived; Neural Cells, PSC-Derived; Neural Stem and Progenitor Cells; Neurons; Pluripotent Stem Cells; Prostate Cells
• Species: Human
• Area of Interest: Epithelial Cell Biology, Neuroscience, Stem Cell Biology

Manufacturer Information:
STEMCELL Technologies Canada Inc. is a Canadian biotechnology company that develops and manufactures cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research. The company has offices in the United States, Europe, Asia, and Australia, with the headquarters in Vancouver, British Columbia, Canada. Allen Eaves, the founder, currently serves as the President and CEO.